Where Does Mpox Stand Now? Evaluating the Threat

A resurgence of mpox was alarming enough that it was labeled a 'public health emergency on a continental scale.' How has the situation evolved, especially with diminished U.S. aid?

Mpox's Reach Across Africa

In regions such as Mombasa, Kenya, healthcare workers like Caroline Mugun observe the severe discomfort endured by mpox patients who are isolated to prevent the virus from spreading further.

Initially unknown in Kenya, mpox has now been identified in the capital and is part of a broader outbreak affecting 26 African countries, a swift ascent from 13 nations in the previous year, as reported by Africa CDC.

Critics highlight serious inadequacies in the global response, despite a financial commitment of $1.1 billion to slow the virus' progression.

Tracing the Virus' Spread

The newly identified strain of mpox, clade 1b, began spreading a year ago, especially among sex workers. Initially concentrated in the Democratic Republic of Congo's eastern regions, it rapidly appeared in neighboring countries.

Over time, the virus has reached far-flung areas including China, the UK, the United States, and Turkey, with Africa suffering major outbreaks, resulting in more than 700 deaths this year according to available data.

Data Gaps and Challenges

Data scarcity stems from various factors: social stigma, rural isolation, and a decrease in U.S. financial aid, notably affecting the Democratic Republic of Congo — a key recipient of those funds.

Despite limited numbers, Africa CDC indicates a recent downward trend in infections, notably in the DRC, Uganda, and Sierra Leone.

The Struggle with Vaccine Deployment

Though mpox is preventable with vaccination, just around 907,000 individuals across 12 African nations have received at least one dose, far below the 10 million doses targeted.

The delay in vaccine rollout highlights the sluggish emergency response by WHO, with doubts raised about the overall urgency in distributing vaccines.

A visit in 2024 by former U.S. President Joe Biden to boost vaccine deliveries fell short, with only 90,000 doses reaching Africa by mid-2025.

Recently, momentum is building for improvement, with additional vaccine shipments authorized and initiation of Kenya's vaccination campaign anticipated soon.

Is the Global Response Adequate?

Experts are voicing concerns over the international health alert system’s effectiveness. If major declarations fail to impact virus containment over a lengthy period, their relevance is questioned.

Despite progress in African countries eventually approving vaccines and establishing extensive laboratory networks, the overall readiness and response are deemed insufficient.

With the virus increasingly embedding itself in human populations, experts warn of its evolvement with every opportunity given.

While the U.S. has largely been spared from major outbreaks so far, experts caution that ignoring diseases abroad risks future domestic health crises.